Tachykinin NK 2 receptor antagonists decrease eicosanoid release in lung anaphylaxis

Author： Montuschi P.   Curro D.   Ciabattoni G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.313, Iss.1, 1996-10, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A role of tachykinin NK 2 receptor antagonists in the treatment of IBS?

By Lecci A.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 11, 2001-11 ,pp. : 551-552

Elsevier

Access to resources Recommend Favorite

Tachykinin NK2 receptor antagonists. A patent review (2006 – 2010)

By Altamura Maria  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 1, 2012-01 ,pp. : 57-77

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the Tachykinin NK2 Receptor [General Reviews]

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 331-340

Bentham Science Publishers

Access to resources Recommend Favorite

An investigation of tachykinin NK 2 receptor subtypes in the rat

By Matuszek M.A.   Zeng X.-P.   Strigas J.   Burcher E.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

Tachykinin NK1 receptor antagonists for the control of chemotherapy-induced nausea and vomiting

By Gale Jeremy D   O’Neill Brian T   Humphrey John M  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 12, 2001-12 ,pp. : 1837-1847

Informa Healthcare

Access to resources Recommend Favorite